Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Contemp Clin Trials. 2016 Jun 21;49:92–102. doi: 10.1016/j.cct.2016.06.006

Table 2.

Summary of Descriptive and Secondary Endpoint Measures and Testing Occasions

Domain (purpose) Measure (Citation/ Source) Description (alpha based on previous trials) Respondent Testing Occasion
PwD cognitive status (descriptive, possible covariate) MMSE (Folstein, 1999) Cognitive status PwD Screening process
PwD physical health and comorbidities (descriptive, possible covariate) Caregiver assessment of function (CAFU).(Gitlin, 2005) CG proxy report of PwD dependence level (a little to complete help) (alpha =.90) Caregiver Screening process
PwD Quality of life as rated by CG (secondary outcome) QOL-AD (Logsdon, 2002) 12 domains; PwD with MMSE>10 can respond; also proxy report is used Caregiver T1, T2, T3
Demographics (descriptive, possible covariate) Caregiver and PwD Information (US Census + other sources) Basic background characteristics Caregiver T1
Medications (descriptive, possible covariate) PwD and CG medications (Adapted from REACH) Brown bag review of prescription and non-prescription meds Brown bag review T1
PwD physical health (descriptive, possible covariate) SF-36, other health measures CG Proxy report of health Caregiver T1
CG Objective and subjective burden (secondary outcomes) -Upset with behaviors (NPI-C);burden;(Bedard, 2001) Vigilance Items (Hrs. on duty + doing things)(Mahoney, 2003) For each NPI-C behavior, CG rates upset (0=no upset to 4=very upset); Vigilance items ask CG to estimate time spent in care (alpha = .89) Caregiver T1, T2, T3
T1, T2, T3
CG Depressive symptoms (potential moderator) CES-D short form179,(Santor, 1997)188 10-items; sensitive to change; Cut off for depression ≥8 (alpha = .91) Caregiver T1, T2, T3
CG Skill acquisition (secondary outcome) Task Management Strategies Index (Gitlin, 2002)87 Frequency using simplification techniques. Likert scale (1= never use to 5 = always use) (alpha = .80) Caregiver T1, T2, T3
CG Efficacy (secondary outcome) Caregiver confidence using activities (Gitlin, 2008)86 5 items reported on a 10 point scale (0=Not confident, 10=Very confident). Caregiver T1, T2, T3
Activity use and CG use of discretionary time (exploratory outcome) Investigator developed(Gitlin, 2008)86,92 Track use of prescribed activities in treatment arm Caregiver Telephone survey following T3
Treatment implementation - Delivery; Receipt Enactment (description of intervention processes) Intervention Delivery Assessment form Investigator developed (adapted from REACH and refined in pilot work) a) dose (# of contacts); b) intensity (time spent each contact); c) session content; d) CG acceptability (receipt) and perceived benefit (enactment; e) acceptability (receipt) and perceived benefit and activity use (enactment) Interventionist Interventionist completes within 48 hrs. of each
Evaluation of study/ Quality control (descriptive, quality control) Program Evaluation (Adapted from previous studies Caregiver satisfaction with and utility of intervention; quality assurance Caregiver Telephone survey following T3

Note: CG=caregivers; PwD= person with dementia; T1 = baseline, T2 = 3-month follow-up; T3 = 6-month follow-up. We estimate interviews with CGs to average 1½ hours.